These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 31527331

  • 21. Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child-Pugh A patients treated with radical surgery: A retrospective observational study.
    Wu B, Hu X, Jin H, Zhou L, Zhang D, Man Z, Wang Y, Yang S, Pang Q, Liu H, Cui P.
    Medicine (Baltimore); 2019 Oct; 98(43):e17394. PubMed ID: 31651841
    [Abstract] [Full Text] [Related]

  • 22. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.
    Ma XL, Zhou JY, Gao XH, Tian L, Wu J, Zhang CY, Zhou Y, Dai Q, Wang BL, Pan BS, Yang XR, Guo W.
    Clin Chim Acta; 2016 Nov 01; 462():15-22. PubMed ID: 27520748
    [Abstract] [Full Text] [Related]

  • 23. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy.
    Chen PC, Chiu NC, Su CW, Huang YH, Hou MC, Lin HC, Wu JC.
    J Chin Med Assoc; 2019 Jan 01; 82(1):2-10. PubMed ID: 30839396
    [Abstract] [Full Text] [Related]

  • 24. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
    Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Ueki H, Kaneto M, Aibiki T, Okudaira T, Kawakami T, Kawamura T, Yamago H, Suga Y, Miyamoto Y, Tomida H, Azemoto N, Mori K, Miyata H, Ninomiya T, Kawasaki H.
    J Gastroenterol Hepatol; 2016 May 01; 31(5):1031-6. PubMed ID: 26647219
    [Abstract] [Full Text] [Related]

  • 25. Albumin-Bilirubin Score Differentiates Liver Fibrosis Stage and Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Virus Infection: A Retrospective Cohort Study.
    Fujita K, Nomura T, Morishita A, Oura K, Yoneyama H, Kobara H, Tsutsui K, Himoto T, Masaki T.
    Am J Trop Med Hyg; 2019 Jul 01; 101(1):220-225. PubMed ID: 31115300
    [Abstract] [Full Text] [Related]

  • 26. Validation of the albumin-indocyanine green evaluation model in patients with resected hepatocellular carcinoma and comparison with the albumin-bilirubin score.
    Russolillo N, Forchino F, Conci S, Mele C, Langella S, Ruzzenente A, Scoleri I, Giuliante F, Guglielmi A, Ferrero A.
    J Hepatobiliary Pancreat Sci; 2019 Jan 01; 26(1):51-57. PubMed ID: 30537424
    [Abstract] [Full Text] [Related]

  • 27. Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection.
    Chong CCN, Lee KF, Chu CM, Chan AWH, Wong J, Chan SL, Lok HT, Fung AKY, Fong AKW, Cheung YS, Yu SCH, Johnson P, Lai PBS.
    HPB (Oxford); 2018 Jun 01; 20(6):546-554. PubMed ID: 29352659
    [Abstract] [Full Text] [Related]

  • 28. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Hansmann J, Evers MJ, Bui JT, Lokken RP, Lipnik AJ, Gaba RC, Ray CE.
    J Vasc Interv Radiol; 2017 Sep 01; 28(9):1224-1231.e2. PubMed ID: 28688815
    [Abstract] [Full Text] [Related]

  • 29. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy.
    Wang ZX, Peng W, Zhang XY, Wen TF, Li C.
    Medicine (Baltimore); 2021 Mar 19; 100(11):e24476. PubMed ID: 33725934
    [Abstract] [Full Text] [Related]

  • 30. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals.
    Casadei Gardini A, Foschi FG, Conti F, Petracci E, Vukotic R, Marisi G, Buonfiglioli F, Vitale G, Ravaioli F, Gitto S, Verucchi G, Lenzi M, Bolondi L, Mazzella G, Brillanti S, Andreone P, member of the Bologna DAA group.
    Dig Liver Dis; 2019 May 19; 51(5):681-688. PubMed ID: 30327251
    [Abstract] [Full Text] [Related]

  • 31. Albumin-Bilirubin Score vs Model for End-Stage Liver Disease in Predicting Post-Hepatectomy Outcomes.
    Fagenson AM, Gleeson EM, Pitt HA, Lau KN.
    J Am Coll Surg; 2020 Apr 19; 230(4):637-645. PubMed ID: 31954813
    [Abstract] [Full Text] [Related]

  • 32. An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan Criteria.
    Ho SY, Liu PH, Hsu CY, Hsia CY, Su CW, Huang YH, Lei HJ, He YJ, Hou MC, Huo TI.
    Am J Clin Oncol; 2019 Sep 19; 42(9):698-704. PubMed ID: 31335351
    [Abstract] [Full Text] [Related]

  • 33. Application of the Albumin-Bilirubin Grade in Predicting the Prognosis of Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Xu L, Wu J, Lu W, Yang C, Liu H.
    Transplant Proc; 2019 Dec 19; 51(10):3338-3346. PubMed ID: 31732203
    [Abstract] [Full Text] [Related]

  • 34. Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection.
    Tsai YC, Sou FM, Liu YW, Wu YJ, Yong CC, Chen DW, Huang PY, Cho WR, Chuang CH, Hsiao CC, Hu TH, Tsai MC.
    BMC Gastroenterol; 2021 Oct 19; 21(1):386. PubMed ID: 34666694
    [Abstract] [Full Text] [Related]

  • 35. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC.
    Zhang ZQ, Xiong L, Zhou JJ, Miao XY, Li QL, Wen Y, Zou H.
    World J Surg Oncol; 2018 Oct 16; 16(1):208. PubMed ID: 30326907
    [Abstract] [Full Text] [Related]

  • 36. Predictive effects of a combined indicator in patients with hepatocellular carcinoma after thermal ablation.
    Yang Q, Yu XL, Wang Y, Cheng ZG, Han ZY, Liu FY, Qian TG, Yu J, Liang P.
    J Cancer Res Ther; 2020 Sep 16; 16(5):1038-1050. PubMed ID: 33004745
    [Abstract] [Full Text] [Related]

  • 37. Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
    Ho SY, Hsu CY, Liu PH, Hsia CY, Su CW, Huang YH, Hou MC, Huo TI.
    Eur J Surg Oncol; 2019 May 16; 45(5):776-781. PubMed ID: 30401507
    [Abstract] [Full Text] [Related]

  • 38. Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients.
    Liang X, Liangliang X, Peng W, Tao Y, Jinfu Z, Ming Z, Mingqing X.
    Sci Rep; 2021 Jul 16; 11(1):14624. PubMed ID: 34272447
    [Abstract] [Full Text] [Related]

  • 39. Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery.
    Cho WR, Hung CH, Chen CH, Lin CC, Wang CC, Liu YW, Wu YJ, Yong CC, Chen KD, Tsai YC, Hu TH, Tsai MC.
    Sci Rep; 2020 Apr 29; 10(1):7290. PubMed ID: 32350365
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.